 | • レポートコード：B-MOR-040934 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、電気生理関連装置の世界市場について調べ、電気生理関連装置の世界規模、市場動向、市場環境、製品別（電気生理学的モニタリング装置、ホルター心電計、電気生理学的治療装置）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・電気生理関連装置の世界市場インサイト ・電気生理関連装置の世界市場環境 ・電気生理関連装置の世界市場動向 ・電気生理関連装置の世界市場規模 ・電気生理関連装置の世界市場規模：製品別（電気生理学的モニタリング装置、ホルター心電計、電気生理学的治療装置） ・電気生理関連装置の世界市場：地域別市場規模・分析 ・電気生理関連装置の北米市場規模・予測 ・電気生理関連装置のアメリカ市場規模・予測 ・電気生理関連装置のヨーロッパ市場規模・予測 ・電気生理関連装置のアジア市場規模・予測 ・電気生理関連装置の日本市場規模・予測 ・電気生理関連装置の中国市場規模・予測 ・電気生理関連装置のインド市場規模・予測 ・電気生理関連装置の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global electrophysiology market has been estimated to register a CAGR of 6.5% during the forecast period 2018 to 2023. Although North America dominates the market due to increasing incidences of heart failure and rapid technological advancements, APAC is expected to register the highest CAGR due to increasing cases of arrhythmia and
high adoption rates in emerging market.
Growing Incidence of Arrhythmia and Heart Failure
In Europe and North America, 1-2% of the total healthcare expenditure is attributed to heart failure. In 2016, around 5.5 million people were diagnosed with heart failure in the United States. It is expected that this number would become 8 million by 2030. Since electrophysiology devices has their major applications in detecting the heart failure rates, the increasing cases of heart failures are expected to drive the market in the forecast period.
In addition, rapid growth in ageing population is responsible to increase heart failure rates which is further attributed to contribute in the growth of global electrophysiology market.
Lack of Skilled and Experienced Electro physiologists
As of 2017, in the United States, approximately 6-8% of cardiologists hold a specialization in electrophysiology. Although not a favorable percentage, the EP workforce is more or less stable in the United States. However, due to lack of mobility among the majority of established electro physiologist, there exists a distinct lag in geographical dispersion of the EPs, resulting in a rift between the demand and supply, and a visible disparity among electro physiologists. These lack of skilled electro physiologists is acting as a major restraint for the global electrophysiology market.
Additionally, unfavorable healthcare reforms along with lack of proper reimbursement policies are also responsible for hindering the growth of the market.
North America to Dominate the Market
The electrophysiology market is segmented by product type, and geography. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America.
North America dominates the electrophysiology market due to the presence of well-established healthcare facilities and rise in number of arrhythmia and heart failure cases in the region. Asia-Pacific is also expected to propel the electrophysiology market owing to factors, such as increasing accessibility to healthcare facilities in the region, rising medical tourism, and increasing incidences of heart failure cases.
Key Developments in the Market
• January 2018: BioSig Technologies, a medical device company which is developing a biomedical signal processing platform designed to address the demand for electrophysiology market has partnered with Mr. Charles Austin and JK advisors to scale up operational activities.
• January 2018: Rhythmlink announced patent license agreement with Dignity Health for improving and expanding brain health monitoring options. The proprietary technology by Dignity Health allows quick and easy collection of EEG data which can be further distributed to healthcare personnel for analysis and intervention.
Key players: ABBOTT LABORATORIES, BOSTON SCIENTIFIC, BIOTRONIK SE & CO. KG, GE HEALTHCARE, HANSEN MEDICAL, JOHNSON & JOHNSON, MEDTRONIC INC., SIEMENS HEALTHCARE, NIHON KOHDEN CORPORATION, and MICROPORT
Reasons to Purchase this Report
• Market analysis for the Global electrophysiology Market, with region-specific assessments and competition analysis on a global and regional scale.
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES ANALYSIS
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 GROWING INCIDENCE OF ARRHYTHMIA AND HEART FAILURE
6.1.2 HIGH ADOPTION RATES IN EMERGING MARKETS DUE TO TECHNOLOGICAL ADVANCEMENTS
6.1.3 RAPID GROWTH IN AGING POPULATION
6.1.4 INCREASING DEMAND FOR CATHETER ABLATION PROCEDURES
6.2 MARKET RESTRAINTS
6.2.1 LACK OF SKILLED AND EXPERIENCED ELECTROPHYSIOLOGISTS
6.2.2 UNFAVORABLE HEALTHCARE REFORMS
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 SEGMENTATION-BY PRODUCTS
7.1.1 ELECTROPHYSIOLOGY MONITORING DEVICES
7.1.1.1 ELECTROCARDIOGRAPH (ECG)
7.1.1.2 ELECTROENCEPHALOGRAPH (EEG)
7.1.1.3 ELECTROCORTICOGRAPH (ECOG)
7.1.1.4 ELECTROMYOGRAPH (EMG)
7.1.1.5 ELECTRORETINOGRAPH (ERG)
7.1.1.6 ELECTROOCULOGRAPH (EOG)
7.1.2 HOLTER MONITORING DEVICES
7.1.2.1 X-RAY SYSTEMS
7.1.2.2 IMAGING AND 3D MAPPING SYSTEMS
7.1.2.3 DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS
7.1.3 ELECTROPHYSIOLOGY TREATMENT DEVICES
7.1.3.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)
7.1.3.2 PACEMAKERS
7.1.3.3 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRTS)
7.1.3.4 CATHETERS
7.1.3.4.1 RADIOFREQUENCY ELECTROPHYSIOLOGY ABLATION CATHETERS
7.1.3.4.2 CRYOABLATION ELECTROPHYSIOLOGY CATHETERS
7.1.3.4.3 LASER ABLATION CATHETERS
7.1.3.4.4 MICROWAVE ABLATION CATHETERS
7.2 SEGMENTATION-BY GEOGRAPHY
7.2.1 NORTH AMERICA
7.2.1.1 UNITED STATES
7.2.1.2 CANADA
7.2.1.3 MEXICO
7.2.2 EUROPE
7.2.2.1 FRANCE
7.2.2.2 GERMANY
7.2.2.3 UNITED KINGDOM
7.2.2.4 ITALY
7.2.2.5 SPAIN
7.2.2.6 REST OF EUROPE
7.2.3 ASIA-PACIFIC
7.2.3.1 CHINA
7.2.3.2 JAPAN
7.2.3.3 INDIA
7.2.3.4 AUSTRALIA & NEW ZEALAND
7.2.3.5 SOUTH KOREA
7.2.3.6 REST OF ASIA-PACIFIC
7.2.4 MIDDLE EAST & AFRICA
7.2.4.1 GCC
7.2.4.2 SOUTH AFRICA
7.2.4.3 REST OF THE MIDDLE EAST & AFRICA
7.2.5 SOUTH AMERICA
7.2.5.1 BRAZIL
7.2.5.2 ARGENTINA
7.2.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS & ACQUISITION ANALYSIS
8.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
8.3 NEW PRODUCTS LAUNCHES
9. KEY PLAYERS
9.1 ABBOTT LABORATORIES
9.2 BOSTON SCIENTIFIC
9.3 BIOTRONIK SE & CO. KG
9.4 GE HEALTHCARE
9.5 HANSEN MEDICAL
9.6 JOHNSON & JOHNSON
9.7 MEDTRONIC INC.
9.8 SIEMENS HEALTHCARE
9.9 NIHON KOHDEN CORPORATION
9.10 MICROPORT
9.11 OTHERS
10. FUTURE OF THE MARKET